NCT06028373 2025-06-09
A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas
Antengene Corporation
Phase 1 Recruiting
Antengene Corporation
Eucure (Beijing) Biopharma Co., Ltd
Bristol-Myers Squibb
The First People's Hospital of Lianyungang